Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Avian influenza: 1st human case detected in B.C.

<< Previous

Bullboard Posts

Next >>

Comment by thadeushon Nov 13, 2024 1:54pm

177 Views

Post# 36310742

RE:RE:RE:Avian influenza: 1st human case detected in B.C.

I was just pointing out the severity of the upcoming situation. No part of of my post was false - in fact it was probably too generous to the new admin. But I will try to refrain from pointing out how dangerous the things will be going forward.

Nevertheless, Theralase is in a position to offer many extremely beneficial therapies.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant